Coronavirus: Penyakit Lama, Virus Lama, Kemasan Baru
Abstract
Abstract— Covid -19, a virus strain and a member of family with known member as Severe Acute Respiratory Disease (SARS) or Middle East Respiratory Syndrome (MERS), but having a potentially lethal differences in not readily recognized by our immunity. Classified as betacoronavirus, with incubation period up to 14 days, the sign and symptoms can be highly variable, from asymptomatic to mild to criticalin the form of severe pneumonia. Almost half the persons infected did not show any symptoms, but in cases of people with comorbidities such as advanced age, pregnancy, obesity or other certain diseases, could increase the likelihood of morbidity and even potentially fatal. Covid-19 has spread globally, including Indonesia, with a potentially increased number of cases, prevention in covid-19 protocol is a necessity.
Keywords: Covid-19, SARS, symptoms, variable, prevention
Abstrak— Covid-19, yang sebelumnya dikenal sebagai virus strain dari kelompok family yang sama dengan Severe Acute Respiratory Disease (SARS) atau Middle East Respiratory Syndrome (MERS), tapi memiliki fatalitas yang secara potensial lebih tinggi, karena bersiafat novel bagi sistem imunitas kita. Termasuk betacoronavirus, dengan masa inkubasi sampai dengan 14 hari, tanda dan gejala penyakit bisa sangat bervariasi, mulai dari asimtomatik, ringan sampai berat, dalam bentuk pneumonia berat. Hamper separuh penderita yang terinfeksi tidak menunjukkan gejala sama sekali, tapi pada penderita dengan komorbiditas seperti usia lanjut, kehamilan, obesitas atau penyakit kronis tertentu, resiko moribiditas dan mortalitas dapat meningkat. Covid-19 saat ini sudah menyebar ke seluruh dunia, termasuk Indonesia, dengan adanya potensi kenaikan kasus lebih banyak, pencegahan dalam bentuk protocol covid-19 bersifat mutlak diperlukan.
Kata kunci: Covid-19, SARS, gejala, bervariasi, pencegahan
Downloads
References
- Chen, N. et al. (2020) ‘Articles Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan , China : a descriptive study’, The Lancet. Elsevier Ltd, 6736(20), pp. 1–7. doi: 10.1016/S0140-6736(20)30211-7.
- Guo, L. et al. (2019) ‘Clinical Features Predicting Mortality Risk in Patients With Viral Pneumonia : The MuLBSTA Score’, 10(December), pp. 1–10. doi: 10.3389/fmicb.2019.02752.
- Ipc, W. H. O. (2020) ‘Infection prevention and control during health care when novel coronavirus ( nCoV ) infection is suspected Interim guidance January 2020’, (January), pp. 1–3.
- Lai, S. et al. (2020) ‘Preliminary risk analysis of 2019 novel coronavirus spread within and beyond China’, 2020.
- Lonski, J. (2020) ‘Coronavirus May Be a Black Swan Like No Other’.
- Belouzard, S. (2012) ‘Mechanisms of Coronavirus Cell Entry Mediated by the Viral Spike Protein’, pp. 1011–1033. doi: 10.3390/v4061011.
- American Thoracic Society (2020) ‘Novel Wuhan ( 2019-nCoV ) Coronavirus’, pp. 2019–2020. doi: 10.1164/rccm.2014P7.
- Tok, T. T. and Tatar, G. (2017) ‘Structures and Functions of Coronavirus Proteins : Molecular Modeling of Viral Nucleoprotein -’, 2(June), pp. 1–7.
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
- Articles published in Keluwih: JKK are licensed under a Creative Commons Attribution-ShareAlike 4.0 International license. You are free to copy, transform, or redistribute articles for any lawful purpose in any medium, provided you give appropriate credit to the original author(s) and the journal, link to the license, indicate if changes were made, and redistribute any derivative work under the same license.
- Copyright on articles is retained by the respective author(s), without restrictions. A non-exclusive license is granted to Kluwih: JKK to publish the article and identify itself as its original publisher, along with the commercial right to include the article in a hardcopy issue for sale to libraries and individuals.
- By publishing in Keluwih: JKK, authors grant any third party the right to use their article to the extent provided by the Creative Commons Attribution-ShareAlike 4.0 International license.